BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/17/2022 3:19:26 AM | Browse: 160 | Download: 248
 |
Received |
|
2021-04-14 14:52 |
|
Peer-Review Started |
|
2021-04-14 14:54 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-09-28 04:13 |
|
Revised |
|
2021-11-05 09:05 |
|
Second Decision |
|
2022-05-05 03:14 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-05-07 00:13 |
|
Articles in Press |
|
2022-05-07 00:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-12-09 02:17 |
|
Typeset the Manuscript |
|
2022-06-09 00:43 |
|
Publish the Manuscript Online |
|
2022-06-17 03:19 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Respiratory System |
| Manuscript Type |
Case Report |
| Article Title |
Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shimon Izhakian, Barak Pertzov, Dror Rosengarten and Mordechai R Kramer |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shimon Izhakian, MD, PhD, Doctor, Pulmonary institute, Rabin medical center, 39 Jabotinski St., Petah Tikva, Petach Tikva 49100, Please Select, Israel. shimixyz@gmail.com |
| Key Words |
Benralizumab; Eosinophilic pneumonia; Interstitial lung disease; Corticosteroid withdrawal; Case report |
| Core Tip |
Chronic eosinophilic pneumonia (CEP) is an idiopathic pulmonary disease, characterized by marked eosinophil accumulation in the pulmonary parenchyma. Currently, the mainstay of CEP treatment is corticosteroids. However, relapse is common, requiring long-term use of corticosteroids, with the risk of significant treatment-related adverse effects. Herein, we describe a patient with an acute CEP relapse, successfully treated with benralizumab alone, without corticosteroids. Currently, only three patients with acute relapse of CEP, were reported successfully treated with benralizumab alone, without corticosteroids. This therapy option may be particularly beneficial for patients who have previously suffered serious adverse effects from or have any contraindications to chronic corticosteroid treatment. |
| Publish Date |
2022-06-17 03:19 |
| Citation |
Izhakian S, Pertzov B, Rosengarten D, Kramer MR. Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report. World J Clin Cases 2022; 10(18): 6105-6109 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i18/6105.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i18.6105 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
